Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 3Prostatic Neoplasms 2Fatigue 2Breast Neoplasms 2Xerostomia 1Vomiting 1Uterine Cervical Neoplasms 1Psychological Well-Being 1Parasomnias 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Obesity 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nausea 1Multiple Myeloma 1Mucositis 1Motor Activity 1Mesothelioma 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Lung Diseases 1Liver Neoplasms 1Hyperinsulinism 1Head and Neck Neoplasms 1Esophagitis 1Digestive System Diseases 1Colon or Upper Rectum Adenocarcinoma 1Brain Neoplasms 1

Interventions

Radiotherapy 2Glutamine 2Fibroblast Growth Factor 7 2oxycodone-acetaminophen 1cyclohexaneacetic acid 1acetaminophen, hydrocodone drug combination 1Surveys and Questionnaires 1Sucralfate 1Standard of Care 1Passive Cutaneous Anaphylaxis 1Pain Management 1Neck Dissection 1Morphine 1Methods 1Methadone 1Laser Therapy 1Ketamine 1Ibuprofen 1Hydromorphone 1Gabapentin 1Fentanyl 1Educational Status 1Early Intervention, Educational 1Doxepin 1Cisplatin 1Benzydamine 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Mucositis × Surveys and Questionnaires × Clear all
NCT01952847 2022-06-15

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

M.D. Anderson Cancer Center

Phase 3 Terminated
77 enrolled 28 charts
Other

Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡